Rituximab Therapy for Primary Sjögren's Syndrome.

Chen, Yi Han; Wang, Xin Yu; Jin, Xin; Yang, Zi; Xu, Jianguang

Chen, Yi Han; Wang, Xin Yu; Jin, Xin; Yang, Zi; Xu, Jianguang.

Afiliação

Chen YH; Key Laboratory of Oral Disease Research of Anhui Province, Stomatologic Hospital AndCollege, Anhui Medical University, Hefei, China.
Wang XY; Key Laboratory of Oral Disease Research of Anhui Province, Stomatologic Hospital AndCollege, Anhui Medical University, Hefei, China.
Jin X; Key Laboratory of Oral Disease Research of Anhui Province, Stomatologic Hospital AndCollege, Anhui Medical University, Hefei, China.
Yang Z; Key Laboratory of Oral Disease Research of Anhui Province, Stomatologic Hospital AndCollege, Anhui Medical University, Hefei, China.
Xu J; Key Laboratory of Oral Disease Research of Anhui Province, Stomatologic Hospital AndCollege, Anhui Medical University, Hefei, China.

Front Pharmacol ; 12: 731122, 2021.

Article em En | MEDLINE | ID: mdl-34539411

Palavras-chave

B cell repopulation; B-cell depletion; anti-CD20 therapy; primary Sjögren's syndrome; rituximab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google